What is the evidence for induced hypothermia (therapeutic cooling) post cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Therapeutic Hypothermia Post-Cardiac Arrest

Primary Recommendation

Comatose adult patients (not responding meaningfully to verbal commands) with return of spontaneous circulation after out-of-hospital ventricular fibrillation cardiac arrest should be cooled to 32-34°C for 12-24 hours. 1


Patient Selection Criteria

Definite Indications

  • Out-of-hospital cardiac arrest with VF/pulseless VT as initial rhythm 1
  • Persistent coma after ROSC (Glasgow Coma Scale ≤8, not responding to verbal commands) 1, 2
  • Intubated and mechanically ventilated 1

Probable Benefit (Weaker Evidence)

  • Non-shockable rhythms (asystole, PEA) after out-of-hospital arrest 1, 2
  • In-hospital cardiac arrest of cardiac etiology 1
    • Note: A large retrospective study of 8,316 in-hospital arrest patients showed no survival benefit (OR 0.90,95% CI 0.65-1.23), though only 40% achieved target temperatures 3

Contraindications

  • Severe cardiogenic shock or life-threatening arrhythmias 1
  • Pregnancy 1
  • Primary coagulopathy 1
  • Non-cardiac causes of arrest (head injury, drug overdose, cerebrovascular accident) 1

Target Temperature and Duration

Temperature Parameters

  • Target: 32-34°C 1, 2
  • Duration: 12-24 hours 1, 2
  • Critical warning: Do not allow temperature to fall below 32°C as complications (arrhythmias, infection, coagulopathy) increase significantly 4

Timing of Initiation

  • Initiate as soon as possible after ROSC 1, 4
  • Still effective if delayed 4-6 hours 1, 4
  • Registry data showed median initiation at 90 minutes (IQR 60-165 minutes) was not independently associated with outcome, though earlier is theoretically better 1

Cooling Methods

Rapid Induction Phase

Cold IV fluid bolus is the fastest initial method:

  • 30 mL/kg of 4°C normal saline or Ringer's lactate over 30 minutes 1, 2, 4
  • Can reduce core temperature by up to 1.5°C 1
  • Never use rapid IV push due to profound bradycardia risk 4
  • Can be initiated in prehospital setting 1

Maintenance Phase (Additional Methods Required)

Surface cooling:

  • Ice packs to groin, axillae, and neck 1, 4
  • Servo-controlled cooling blankets (water or air circulation) 1, 4
  • Cooling helmets (less common) 1, 4

Intravascular cooling:

  • Endovascular heat exchange catheters provide most precise temperature control 1, 4
  • Too invasive for prehospital/ED use 4
  • Not used in pediatrics due to thrombosis risk 4

Temperature Monitoring

Continuous core temperature monitoring is mandatory 4:

  • Bladder temperature probe (reliable, preferred) 4
  • Esophageal temperature probe (accurate) 4
  • Rectal temperature probe (reliable) 4
  • Pulmonary artery catheter if already in place 4
  • Avoid intermittent tympanic measurements (unreliable) 4

Rewarming Protocol

  • Passive rewarming only 1, 4
  • Avoid rapid active rewarming as rebound hyperthermia is common and worsens outcomes 1, 4
  • Normothermia should be restored slowly 1

Evidence of Benefit

Neurological Outcomes

  • 55% favorable neurological outcome at 6 months with hypothermia vs. 39% with normothermia in the European trial 1
  • Number Needed to Treat = 6 for one additional patient with intact neurological recovery 2, 5, 6
  • Relative risk 1.41 (95% CI 1.12-1.76) for favorable neurological outcome across 11 studies with 3,914 participants 7

Mortality Benefit

  • Relative risk 0.74 (NNT=7) for mortality reduction at 6 months 2
  • Cochrane review confirms mortality benefit with low certainty evidence 7

Concurrent Interventions

Percutaneous Coronary Intervention

Therapeutic hypothermia is feasible and safe during PCI 1, 2

  • Do not delay PCI due to hypothermia 2
  • Five studies confirmed safety of combined hypothermia and PCI 1

Thrombolytic Therapy

  • Not a contraindication to therapeutic hypothermia 1
  • Patients receiving thrombolytics were included in landmark trials 1

Adverse Effects and Management

Common Complications

Increased with hypothermia:

  • Pneumonia (NNH=12) 1, 7
  • Bleeding (NNH=14) 1
  • Sepsis (NNH=16) 1
  • Severe arrhythmias (RR 1.40,95% CI 1.19-1.64) 7
  • Hypokalaemia (RR 1.38,95% CI 1.03-1.84) 7

Metabolic Derangements

  • Hypokalemia, hypophosphatemia, hypomagnesemia, hypocalcemia develop during cooling and may precipitate arrhythmias 4
  • Close electrolyte monitoring required, especially during induction 4
  • Hyperglycemia due to decreased insulin sensitivity 2, 4

Cardiovascular Effects

  • Lower cardiac index and higher systemic vascular resistance 1
  • Bradycardia and hypotension observed 4

Shivering Prevention

Shivering must be prevented as it increases oxygen consumption and causes warming 8, 4:

  • Sedation plus neuromuscular blockade is the standard approach 4
  • This was the protocol used in definitive trials 4

Critical Pitfalls to Avoid

  1. Do not cool below 32°C - complications increase exponentially 4
  2. Do not use rapid IV push of cold saline - causes profound bradycardia 4
  3. Do not allow rapid rewarming - rebound hyperthermia worsens outcomes 1, 4
  4. Do not use intermittent temperature monitoring - continuous monitoring mandatory 4
  5. Do not forget to prevent shivering - negates cooling benefit 8, 4
  6. Do not withhold from hemodynamically compromised patients - hypothermia is safe even in shock 5

Guideline Endorsements

Both the American Heart Association and International Liaison Committee on Resuscitation (ILCOR) recommend therapeutic hypothermia for unconscious adult patients with spontaneous circulation after out-of-hospital VF cardiac arrest 1, 8, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Terapeutic Hypothermia After Cardiac Arrest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Therapeutic Hypothermia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypothermia after cardiac arrest.

Progress in cardiovascular diseases, 2009

Research

Therapeutic hypothermia after cardiac arrest.

Current opinion in anaesthesiology, 2005

Research

Hypothermia for neuroprotection in adults after cardiac arrest.

The Cochrane database of systematic reviews, 2023

Guideline

Therapeutic Hypothermia in Medical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.